# TDH Capital

> TDH Capital is a VC fund in Radnor backing FinTech, Medical and E-Commerce. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Radnor, United States
- Total investments: 3
- Last investment: Feb 2022
- Lead investor: 0%
- Last updated: Aug 2026

TDH Capital is a VC fund in Radnor focused on FinTech and Medical. TDH Capital invests in early stage, mid stage, late stage, middle market, and mature transactions.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| FinTech | 1 | 33% |
| Medical | 1 | 33% |
| E-Commerce | 1 | 33% |
| Communities | 1 | 33% |
| Health Care | 1 | 33% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 2 | 67% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| YouScribe | YouScribe is the French community platform for sharing and selling digital publications. | $5.7M | Venture - Series Unknown | Feb 11, 2022 |  |
| Youdge | Youdge is a digital neo-broker with a aim to make the consumer credit market clear and accessible. | $5.8M | Series A | Oct 29, 2021 |  |
| Ceptaris Therapeutics | Ceptaris Therapeutics, Inc. is a privately held, specialty pharmaceutical company that is developing a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). If approved, Ceptaris' investigational drug would be the first topicalmechlorethamine product available to treat the signs and symptoms of this rare cancer. | $4.5M | Series B | Nov 14, 2006 |  |

3 of 3 investments shown.

## Co-investors
- [Banque des Territoires](https://shizune.co/investors/profile/banque-des-territoires) — VC Fund, 2 deals together
- [Habert Dassault Finance](https://shizune.co/investors/profile/habert-dassault-finance) — VC Fund, 2 deals together
- [Elevation Capital Partners](https://shizune.co/investors/profile/inter-invest-capital) — VC Fund, 2 deals together
- [IRIS Capital Investment](https://shizune.co/investors/profile/iris-capital-investment) — VC Fund, 2 deals together
- [Ben Franklin Technology Partners of Southeastern Pennsylvania](https://shizune.co/investors/profile/ben-franklin-technology-partners-of-southeastern-pennsylvania) — VC Fund, 1 deal together
- [BioAdvance](https://shizune.co/investors/profile/bioadvance) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does TDH Capital invest in?

TDH Capital invests primarily in FinTech, Medical and E-Commerce startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did TDH Capital last invest?

The most recent investment recorded for TDH Capital closed in Feb 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co